Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Clinical Cardiology

inflamed pericardium around heart in human chest

Consensus Document on Pericardial Diseases Brings Needed Guidance on Multimodality Imaging and Therapeutics

Offers recommendations on imaging and treatment across five clinical pericardial syndromes

woman giving subcutaneous self-injection in abdomen

Can Enoxaparin Be Used as a Bridge to Warfarin for Outpatients With LVADs?

Cleveland Clinic series supports its feasibility, especially with HeartMate 3

ventricular tachycardia

Ventricular Arrhythmia-Related Cardiac Arrest Rare After PCI for STEMI

Study identifies a cohort of low-risk patients, finds LVEF predicts late VT/VF in those at higher risk

heart showing obstructive cardiomyopathy

Mavacamten in the Real World: Study Demonstrates Safe Reduction in Eligibility for Septal Reduction Therapy

Logistic feasibility supported for treating obstructive HCM under the REMS program

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

photo of cardiologists working in a cardiac catheterization lab

New AHA Statement Clarifies Cath Lab Role in Out-of-Hospital Cardiac Arrest

Guidance on the often-fatal condition through an interventional cardiology lens

23-HVI-4003412_aorta-illustration_650x450

How the New ACC/AHA Guideline on Aortic Disease Is Starting to Shape Practice

Impacts include major emphases on multidisciplinary teams, shared decision-making

cardiac PET scan

PET/CT With Myocardial Blood Flow Effectively Screens for Cardiac Allograft Vasculopathy

Study validates a noninvasive alternative to invasive coronary angiography

22-HVI-3509429_obstructive-hypertrophic-cardiomyopathy_650x450

Advances in Hypertrophic Cardiomyopathy Therapy: VALOR-HCM May Be Just the Beginning

An abundance of promising studies are on the horizon

22-HVI-3276959_obstructive-HCM-strain-imaging_650x450

Mavacamten’s Effects Against Obstructive Hypertrophic Cardiomyopathy Persist Through 32 Weeks in VALOR-HCM

Latest results confirm and build on 16-week findings

Knowing the signs can save your life

How Autoimmune Disorders Impact Myocardial Infarction Treatment and Long-Term Outcomes

Largest study to date finds lower intervention rates, elevated long-term mortality

BackPage 2 of 4Next

Advertisement

Ad